Sign Up to like & get
recommendations!
1
Published in 2019 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2019.1686057
Abstract: Abstract Background: The Lémann Index (LI) was recently developed to evaluate the cumulative bowel damage in patients with Crohn’s disease (CD). Aims: To search for a difference between adalimumab and azathioprine to halt the progression…
read more here.
Keywords:
bowel;
bowel damage;
progression bowel;
azathioprine ... See more keywords